These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3118699)

  • 21. Platelet aggregation studies for the diagnosis of heparin-induced thrombocytopenia.
    Isenhart CE; Brandt JT
    Am J Clin Pathol; 1993 Mar; 99(3):324-30. PubMed ID: 8447295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation.
    Macfarlane DE; Walsh PN; Mills DC; Holmsen H; Day HJ
    Br J Haematol; 1975 Aug; 30(4):457-63. PubMed ID: 811245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.
    Turner NA; Moake JL; Kamat SG; Schafer AI; Kleiman NS; Jordan R; McIntire LV
    Circulation; 1995 Mar; 91(5):1354-62. PubMed ID: 7867173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of 15 cases with platelet EDTA-dependent antibodies.
    Zupańska B; Maślanka K
    Acta Haematol Pol; 1995; 26(4):361-5. PubMed ID: 8571737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet aggregation following heparin and protamine administration.
    Ellison N; Edmunds LH; Colman RW
    Anesthesiology; 1978 Jan; 48(1):65-8. PubMed ID: 619707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of heparin and extracorporeal circulation on platelet counts and platelet microaggregation during cardiopulmonary bypass.
    Muriithi EW; Belcher PR; Rao JN; Chaudhry MA; Nicol D; Wheatley DJ
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):538-43. PubMed ID: 10962416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin induced platelet aggregation: in vitro confirmation of thrombotic complications associated with heparin therapy.
    Hussey CV; Bernhard VM; McLean MR; Fobian JE
    Ann Clin Lab Sci; 1979; 9(6):487-93. PubMed ID: 518011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pseudothrombocytopenia caused by ethylenediaminetetraacetic acid (EDTA) (case report)].
    Putarek K; Vuk T; Soldo D; Sarlija D; Grgicevic D; Jaksić B
    Lijec Vjesn; 1997 Jan; 119(1):19-21. PubMed ID: 9213726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin prevents heparin-induced platelet aggregation in vivo.
    Janson PA; Moake JL; Garpinito C
    Br J Haematol; 1983 Jan; 53(1):166-8. PubMed ID: 6848119
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet aggregation studies in whole human blood.
    Saniabadi AR; Lowe GD; Forbes CD; Prentice CR; Barbenel JC
    Thromb Res; 1983 Jun; 30(6):625-32. PubMed ID: 6412393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anticoagulant-induced pseudo-thrombocytopenia: an important laboratory artifact].
    Radaelli A; Reiner M; Balestra B
    Praxis (Bern 1994); 1996 Nov; 85(48):1550-2. PubMed ID: 8992567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of a high single subcutaneous dose of unfractionated heparin on platelet function in dogs].
    Mischke R; Nimmerfall K
    Berl Munch Tierarztl Wochenschr; 2000 Feb; 113(2):60-4. PubMed ID: 10726363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin, platelet aggregation, neutrophils, and cardiopulmonary bypass.
    Belcher PR; Muriithi EW; Milne EM; Wanikiat P; Wheatley DJ; Armstrong RA
    Thromb Res; 2000 May; 98(4):249-56. PubMed ID: 10822071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EDTA-dependent pseudothrombocytopenia confirmed by supplementation of kanamycin; a case report.
    Ahn HL; Jo YI; Choi YS; Lee JY; Lee HW; Kim SR; Sim J; Lee W; Jin CJ
    Korean J Intern Med; 2002 Mar; 17(1):65-8. PubMed ID: 12014216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Platelet aggregation tests in 26 cases of heparin-induced thrombopenia. Methodological, diagnostic problems and therapeutic aspects].
    Lecrubier C; Lecompte T; Potevin F; Horellou MH; Conard J; Samama M
    J Mal Vasc; 1987; 12 Suppl B():128-32. PubMed ID: 2834484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudothrombocytopenia in plateletpheresis donors.
    Sweeney JD; Holme S; Heaton WA; Campbell D; Bowen ML
    Transfusion; 1995 Jan; 35(1):46-9. PubMed ID: 7998068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothermia-induced platelet aggregation in heparinized flowing human blood: identification of a high responder subpopulation.
    Hall MW; Goodman PD; Alston SM; Solen KA
    Am J Hematol; 2002 Jan; 69(1):45-55. PubMed ID: 11835331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition and prevention of pseudothrombocytopenia and concomitant pseudoleukocytosis.
    Lombarts AJ; de Kieviet W
    Am J Clin Pathol; 1988 May; 89(5):634-9. PubMed ID: 3128946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature.
    Berkman N; Michaeli Y; Or R; Eldor A
    Am J Hematol; 1991 Mar; 36(3):195-201. PubMed ID: 1899964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient pseudothrombocytopenia in a neonate: transmission of a maternal EDTA-dependent anticoagulant.
    Ohno N; Kobayashi M; Hayakawa S; Utsunomiya A; Karakawa S
    Platelets; 2012; 23(5):399-400. PubMed ID: 21988316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.